MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validation of a New Patient-reported Outcome Scale for the Assessment of Essential Tremor

L. Shih, M. Stevenson, S. Bellows, A. Fasano, S. Kuo, K. Lyons, H. Moore, H. Shill, A. Shukla, C. Singer, R. Elble (Boston, USA)

Meeting: 2024 International Congress

Abstract Number: 1537

Keywords: Depression, Essential tremor(ET), Tremors: Clinical features

Category: Tremor

Objective: Develop and validate a TETRAS PRO subscale

Background: The Essential Tremor Rating Assessment Scale (TETRAS) is a popular scale for essential tremor (ET), but its activities of daily living (ADL) and performance (P) subscales are based on a structured interview and physical exam. No patient-reported outcome (PRO) scale for ET has been developed according to US regulatory guidelines.

Method: Fourteen items, rated 0-4, were derived from TETRAS ADL and structured cognitive interviews of 19 ET patients. Convergent validity analyses of TETRAS PRO versus TETRAS ADL, TETRAS-P, and the Quality of Life in Essential Tremor Questionnaire (QUEST) were computed for 67 adults with ET or ET plus. Test-retest reliability was computed at intervals of 1 and 30 days. The influence of mood (Hospital Anxiety and Depression Scale, HADS) and coping behaviors (Essen Coping Questionnaire, ECQ) was examined with multiple linear regression.

Results: TETRAS PRO was strongly correlated (r>0.7) with TETRAS ADL, TETRAS-P, and QUEST and exhibited good to excellent reliability (Cronbach alpha 95%CI=0.853-0.926; 30-day test-retest intraclass correlation 95%CI=0.814-0.921). The 1-day and 30-day estimates of minimum detectable change (MDC) were 7.2 and 6.6. TETRAS-P (rsemipartial=0.607), HADS depression (rsemipartial= 0.384), and the coping strategy of information seeking and exchange of experiences (rsemipartial=0.176) contributed statistically to TETRAS PRO in a multiple linear regression (R2=0.67).

Conclusion: TETRAS PRO is a valid and reliable scale that is influenced strongly by tremor severity, moderately by mood (depression), and minimally by coping skills. The MDC for TETRAS PRO is likely to be smaller than clinically important change.

To cite this abstract in AMA style:

L. Shih, M. Stevenson, S. Bellows, A. Fasano, S. Kuo, K. Lyons, H. Moore, H. Shill, A. Shukla, C. Singer, R. Elble. Validation of a New Patient-reported Outcome Scale for the Assessment of Essential Tremor [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/validation-of-a-new-patient-reported-outcome-scale-for-the-assessment-of-essential-tremor/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validation-of-a-new-patient-reported-outcome-scale-for-the-assessment-of-essential-tremor/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley